The Global Fibromyalgia Treatment Market Growth Accelerated By Rising Adoption Of Non-Pharmacological Therapies

Fibromyalgia Treatment Market 

 Fibromyalgia is a musculoskeletal disorder characterized by widespread pain, fatigue, sleep, memory and mood issues. Non-pharmacological fibromyalgia treatment includes therapies like physical therapy, meditation, acupuncture and yoga. These therapies help enhance physical functioning, reduce depression and anxiety and improve sleep quality. With growing awareness about the benefits of non-drug therapies for pain management, their adoption has been increasing significantly.


The global Fibromyalgia Treatment Market is estimated to be valued at US$ 1546.59 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising adoption of non-pharmacological therapies is one of the major trends being witnessed in the global fibromyalgia treatment market. According to recent studies, meditation, physical exercise and mindfulness-based cognitive behavior therapy have shown effectiveness equivalent to commonly prescribed medications for fibromyalgia symptoms relief. They offer sustainable pain management with negligible side-effects. As a result, there is growing inclination among healthcare practitioners and patients towards non-drug alternatives. This growing preference for integrated therapeutic approaches using non-pharmacological techniques in fibromyalgia care is expected to drive significant growth of the overall market during the forecast period.

Segment Analysis
The global fibromyalgia treatment market is segmented on the basis of treatment, route of administration, and distribution channel. The treatment segment is further divided into medications and therapies. Medications are the dominating sub-segment owing to the high adoption of prescription drugs for fibromyalgia treatment. Key prescription drugs used in fibromyalgia treatment include duloxetine, pregabalin, milnacipran, and savella.

Key Takeaways
The global fibromyalgia treatment market analysis is expected to witness high growth over the forecast period of 2023 to 2030. The global Fibromyalgia Treatment Market is estimated to be valued at US$ 1546.59 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

Regional analysis: North America is currently the dominant region in the global fibromyalgia treatment market and is expected to continue its dominance over the forecast period. This is attributed to the increasing prevalence of fibromyalgia and higher adoption of advanced treatment options in the region. Europe is also expected to witness above-average growth owing to growing awareness regarding available fibromyalgia treatment options. Asia Pacific is estimated to be the fastest-growing region due to rising healthcare expenditure and increasing patient pool.

Key players: Key players operating in the fibromyalgia treatment market include Autodesk Inc., IES (Integrated Environmental Solutions), Bentley Systems, EnergyPlus, CY
PE Software, DesignBuilder Software, IESVE (IES Virtual Environment), Carrier, eQUEST, Trane Technologies, IES TaP, IES SCAN, Trimble, and EnergySoft. Autodesk Inc., Bentley Systems, and Trimble collectively account for the dominant market share currently due to their extensive product portfolios for structural design and construction management.

 

Comments

Post a Comment

Popular posts from this blog

The Global Naloxone Market Is Set To Experience Exponential Growth Owing To Rising Opioid Overdoses

Image
   naloxone market The naloxone market has experienced significant growth in recent years owing to increasing cases of opioid overdoses across the globe. Naloxone is an opioid antagonist medication used to reverse the effects of opioid overdoses including life-threatening depression of central nervous system and respiratory functions. The global naloxone market is estimated to be valued at US$ 1,422.26 million in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period of 2024-2030. Naloxone is administered as an injection into a muscle or vein or as a nasal spray. It is effective against both natural and synthetic opioids such as morphine, heroin, oxycodone, fentanyl, and methadone. Rising abuse and misuse of prescription opioids and increasing societal acceptability of opioids for pain management have been identified as major causes of opioid epidemics in many countries. Moreover, governmental support through policy and funding initiatives for wider public...
Read more

Feminine Hygiene Products Market Growth Accelerated By Rising Awareness About Women Hygiene

Image
Feminine Hygiene Products Market    Feminine hygiene products provide effective solutions for maintaining women's intimate hygiene and offer convenience during menstrual cycles. Sanitary pads, tampons, panty liners, and menstrual cups are commonly used feminine hygiene products that efficiently absorb menstrual blood flow. The growing awareness about women's hygiene and health and availability of innovative product varieties catering to different needs have accelerated the demand for these products. Factors such as changing lifestyles and rising incomes have further contributed to the increased spending on intimate healthcare needs of women. The global Feminine Hygiene Products Market is estimated to be valued at US$ 41.71 Bn in 2024 and is expected to exhibit a CAGR of 23.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth in the feminine hygiene products...
Read more

The Global Antimicrobial Plastics Market Growth Accelerated By Increased Safety Measures

Image
Antimicrobial Plastics Market   Antimicrobial plastics are a range of plastics that are incorporated with antimicrobial additives which make them capable of destroying microbes and bacteria. They help reduce the growth and spread of microbes and are highly effective against pathogens. These plastics find wide usage in healthcare, packaging, food and beverage industries due to their ability to inhibit microbial growth. The global Antimicrobial Plastics Market is estimated to be valued at US$ 37.35 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increased usage of antimicrobial plastics can be attributed to the rising safety measures across industries. With growing awareness regarding hygiene and safety, antimicrobial plastics are being increasingly used in applications such as food packaging, healthcare and medical devices. Their effecti...
Read more